Target intelligence / Profile preview

RNA, U7 Small Nuclear 12 Pseudogene (RNU7-12P)

Target
RNU7-12P
Molecular classification
Pseudogene, Non-coding RNA (snRNA pseudogene family)
01

Overview

RNA, U7 small nuclear 12 pseudogene (RNU7-12P) is one of many pseudogenes found in the human genome, annotated as a non-coding RNA gene related by sequence to U7 small nuclear RNA (U7 snRNA)[1]. While the functional U7 snRNA is a component of the U7 snRNP complex and is essential for histone pre-mRNA 3′ end processing[3][5], pseudogenes such as RNU7-12P are typically not expressed or functional. Most snRNA pseudogenes are thought to be evolutionary remnants resulting from gene duplication and mutation, and their disrupted or absent transcription means they do not participate in known cellular processes[4][8]. RNU7-12P has no reported protein product, established biological functions, or known regulatory effects, and is not considered a therapeutic target or disease gene[1][4][5]. Some pseudogenes have regulatory roles in rare cases[6][8], but there is no literature or database support for such a role for RNU7-12P. Key insights: - RNU7-12P is best classified as a pseudogene, not as a functional or pharmaceutically relevant target[1][5]. - Most snRNA pseudogenes are not expressed, and there is no evidence that RNU7-12P has regulatory or protein-coding capacity[4][5]. - The gene does not participate in biological pathways, disease processes, or drug interactions[1][5].

Other names
U7.12RNU7-100PRNA, U7 Small Nuclear 100 PseudogeneRNA, Small Nuclear U7.12 Pseudogene

Beyond the preview

Go deeper on RNA, U7 Small Nuclear 12 Pseudogene (RNU7-12P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U7 Small Nuclear 12 Pseudogene (RNU7-12P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call